PMC:7402624 / 4489-4744 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"103","span":{"begin":44,"end":52},"obj":"Species"},{"id":"104","span":{"begin":239,"end":246},"obj":"Species"},{"id":"105","span":{"begin":35,"end":43},"obj":"Disease"}],"attributes":[{"id":"A103","pred":"tao:has_database_id","subj":"103","obj":"Tax:9606"},{"id":"A104","pred":"tao:has_database_id","subj":"104","obj":"Tax:9606"},{"id":"A105","pred":"tao:has_database_id","subj":"105","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Because potential therapeutics for COVID-19 patients include approaches to inhibit, activate, or otherwise modulate immune function, it is essential to define the immune response characteristics related to disease features in well-defined patient cohorts."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T32","span":{"begin":35,"end":43},"obj":"Disease"}],"attributes":[{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Because potential therapeutics for COVID-19 patients include approaches to inhibit, activate, or otherwise modulate immune function, it is essential to define the immune response characteristics related to disease features in well-defined patient cohorts."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T48","span":{"begin":84,"end":92},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Because potential therapeutics for COVID-19 patients include approaches to inhibit, activate, or otherwise modulate immune function, it is essential to define the immune response characteristics related to disease features in well-defined patient cohorts."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T24","span":{"begin":163,"end":178},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"Because potential therapeutics for COVID-19 patients include approaches to inhibit, activate, or otherwise modulate immune function, it is essential to define the immune response characteristics related to disease features in well-defined patient cohorts."}

{"project":"LitCovid-sentences","denotations":[{"id":"T33","span":{"begin":0,"end":255},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Because potential therapeutics for COVID-19 patients include approaches to inhibit, activate, or otherwise modulate immune function, it is essential to define the immune response characteristics related to disease features in well-defined patient cohorts."}